A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway

A 31-gene signature derived by integrating four different microarray experiments, has been found to have a potential for predicting radiosensitivity of cancer cells, but it was seldom validated in clinical cancer samples. We proposed that the gene signature may serve as a predictive biomarker for estimating the overall survival of radiation-treated patients. The significance of gene signature was tested in two previously published datasets from Gene Expression Omnibus (GEO) and The Cancer Genome Altas (TCGA), respectively. In GEO data set, patients predicted to be radiosensitive(RS) had an improved overall survival when compared with radioresistant(RR) patients in either radiotherapy(RT)-treated or non radiotherapy(RT)-treated subgroups(p<0.0001 in the RT-treated group). Multivariate Cox regression analysis showed that the gene signature is the strongest predictor(p=0.0093) in the RT-treated subgroup of patients. However, it does not remain significant (p=0.7668) in non radiotherapy-treated group when adjusting for age and Karnofsky performance score (KPS) as covariates. Similarly, in the TCGA data set, radiotherapy-treated glioblastoma multiforme(GBM) patients assigned to RS group had an improved overall survival compared with RR group(p<0.0001). Geneset enrichment analysis(GSEA) analysis revealed that enrichment of epithelial mesenchymal transition(EMT) pathway was observed with radioresistant phenotype. These results suggest that the signature is a predictive biomarker for radiation-treated glioma patients' prognostic.

[1]  L. Deangelis,et al.  Glioblastoma and other malignant gliomas: a clinical review. , 2013, JAMA.

[2]  David Boulware,et al.  A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation. , 2009, International journal of radiation oncology, biology, physics.

[3]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[4]  R. Weichselbaum,et al.  New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology , 2013, Science Translational Medicine.

[5]  T. Golub,et al.  Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. , 2003, Cancer research.

[6]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[7]  S. Murray,et al.  Repression of PTEN Phosphatase by Snail1 Transcriptional Factor during Gamma Radiation-Induced Apoptosis , 2008, Molecular and Cellular Biology.

[8]  Tatsuya Ohno,et al.  Subtypes of cervical adenosquamous carcinomas classified by EpCAM expression related to radiosensitivity , 2010, Cancer biology & therapy.

[9]  Se Hoon Kim,et al.  Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. , 2013, Cancer cell.

[10]  P. French,et al.  Genetic Alterations in Glioma , 2011, Cancers.

[11]  D. Hirst,et al.  Molecular biology: the key to personalised treatment in radiation oncology? , 2010, The British journal of radiology.

[12]  Andrew P. Stubbs,et al.  Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. , 2009, Cancer research.

[13]  Xiaomin Su,et al.  Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition. , 2011, International journal of radiation oncology, biology, physics.

[14]  G. Reifenberger,et al.  Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Glas,et al.  The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study , 2009, Breast Cancer Research and Treatment.

[16]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[17]  Yi-Hong Zhou,et al.  Linking differential radiation responses to glioma heterogeneity , 2014, Oncotarget.

[18]  A. Hart,et al.  Validation of 70-gene prognosis signature in node-negative breast cancer , 2009, Breast Cancer Research and Treatment.

[19]  Yudi Pawitan,et al.  Validation of a Radiosensitivity Molecular Signature in Breast Cancer , 2012, Clinical Cancer Research.

[20]  F. Ducray,et al.  Predictive and prognostic factors for gliomas , 2011, Expert review of anticancer therapy.

[21]  P. Kleihues,et al.  IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas , 2009, Clinical Cancer Research.

[22]  R. Komotar,et al.  Predictors of Long-Term Survival in Patients With Glioblastoma Multiforme: Advancements From the Last Quarter Century , 2013, Cancer investigation.

[23]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[24]  F. Chibon,et al.  Cancer gene expression signatures - the rise and fall? , 2013, European journal of cancer.

[25]  T. Beißbarth,et al.  Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  Hemant Ishwaran,et al.  An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer , 2008, Proceedings of the National Academy of Sciences.

[27]  Annuska M. Glas,et al.  The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer , 2010, Breast Cancer Research and Treatment.

[28]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[29]  J. Gray,et al.  Genetic Differences in Transcript Responses to Low-Dose Ionizing Radiation Identify Tissue Functions Associated with Breast Cancer Susceptibility , 2012, PloS one.

[30]  Crispin J. Miller,et al.  Investigation of Radiosensitivity Gene Signatures in Cancer Cell Lines , 2014, PloS one.

[31]  P. Lambin,et al.  E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[32]  K. Somasundaram,et al.  Integrated Systems and Technologies A DNA Methylation Prognostic Signature of Glioblastoma : Identi fi cation of NPTX 2-PTEN-NFk B Nexus , 2013 .

[33]  A. Begg.  Predicting response to radiotherapy: Evolutions and revolutions , 2009, International journal of radiation biology.

[34]  T. Beißbarth,et al.  A gene expression signature for chemoradiosensitivity of colorectal cancer cells. , 2010, International journal of radiation oncology, biology, physics.

[35]  Yong Li,et al.  Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy , 2014, Cancer and Metastasis Reviews.

[36]  M. Tatari,et al.  EMT as the ultimate survival mechanism of cancer cells. , 2012, Seminars in cancer biology.

[37]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .

[38]  S. Asuthkar,et al.  Epigenetic Regulation of miRNA-211 by MMP-9 Governs Glioma Cell Apoptosis, Chemosensitivity and Radiosensitivity , 2012, Oncotarget.

[39]  Frank J P Hoebers,et al.  Gene expression profiling to predict outcome after chemoradiation in head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.

[40]  S. Horvath,et al.  Gene Expression Profiling of Gliomas Strongly Predicts Survival , 2004, Cancer Research.

[41]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  B. Fisher,et al.  Adult supratentorial low-grade glioma: long-term experience at a single institution. , 2009, International journal of radiation oncology, biology, physics.

[43]  Arthur Liberzon,et al.  Using GenePattern for Gene Expression Analysis , 2008, Current protocols in bioinformatics.

[44]  S. Friend,et al.  Cancer Biomarkers—An Invitation to the Table , 2006, Science.

[45]  Bertil Romner,et al.  Current treatment of low grade astrocytoma: A review , 2013, Clinical Neurology and Neurosurgery.

[46]  Gabriele Schackert,et al.  Long-term survival with glioblastoma multiforme. , 2007, Brain : a journal of neurology.

[47]  A. Ghanate,et al.  Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53‐Mediated Apoptosis and Acquiring a Stem‐Like Phenotype in Ovarian Cancer Cells , 2009, Stem cells.

[48]  Steven Eschrich,et al.  Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform. , 2009, International journal of radiation oncology, biology, physics.

[49]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[50]  P. Kleihues,et al.  Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. , 2005, Journal of neuropathology and experimental neurology.